Sec Form 13D Filing - AUSTRALIS CAPITAL INC filing for BODY & MIND INC. (BAMM) - 2021-09-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 10)*

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  [   ].

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

Notes:

(1)Based on 101,698,593 common shares of the Issuer's common stock issued and outstanding as of September 9, 2021. 

Page 2

Item 1.Security and Issuer 

This statement constitutes Amendment No. 10 to the Schedule 13D relating to the voting common stock, with a par value of CAD$0.0001, of Body and Mind Inc., a corporation organized under the laws of the State of Nevada (the "Issuer"), and hereby amends the Schedule 13D filed with the Securities and Exchange Commission on December 31, 2018 (the “Initial Schedule 13D”), as amended by: Amendment No. 1 filed with the Securities and Exchange Commission (“SEC”) on December 31, 2018; Amendment No. 2 filed with the SEC on February 6, 2019; Amendment No. 3 filed with the SEC on May 28, 2019; Amendment No. 4 filed with the SEC on July 3, 2019; Amendment No. 5 filed on December 5, 2019; Amendment No.6 filed on May 27, 2020; Amendment No. 7 filed on June 24, 2020; Amendment No. 8 filed on July 6, 2020; and Amendment No. 9 filed on August 30, 2021.

The Issuer maintains its principal executive office at 750 – 1095 West Pender Street, Vancouver, British Columbia, Canada, V6E 2M6.

Item 2.Identity and Background 

Name:

This statement is filed by Australis Capital Inc. (the "Reporting Person").  All decisions with respect to securities of the Issuer (including investments decisions with respect thereto and decisions relating to the voting thereof) are made by the board of directors of the Reporting Person.

Residence or Business Address:

376 East Warm Springs Road
Suite 190
Las Vegas, Nevada 89119

Present Principal Business or Occupation:

The Reporting Person operates businesses focused on the cannabis industry in the United States through its subsidiaries and other entities in which it holds interests.  The Reporting Person’s business activities may include the acquisition of equity, debt or other securities of publicly traded or private companies or other entities, financing in exchange for predetermined royalties or distributions, and the acquisition of all or part of one or more businesses, portfolios or other assets.

Place of Organization or Citizenship:

Australis Capital Inc. is a corporation organized under the laws of the Province of Alberta, Canada.

Criminal Proceedings:

During the last five years, the Reporting Person has not been convicted in any criminal proceeding.

Civil Proceedings:

During the last five years, the Reporting Person has not been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction where, as a result of such proceeding, there was or is a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3.Source and Amount of Funds or Other Considerations 

On September 2, 2021, the Reporting Person sold to Toro Pacific Management Inc. (“TPMI”) and certain other purchasers of the Common Shares (together with TPMI, the “Purchasers”) 5,900,000 shares of Common Stock (the “Common Shares”) of the Issuer pursuant to a share purchase agreement (the “Agreement”) between the Reporting Person and the Purchasers dated August 31, 2021.

Page 3

Item 4.Purpose of Transaction 

Pursuant to the Agreement, the Reporting Person sold 5,900,000 Common Shares to the Purchasers at a price of $0.30 per Common Share on September 2, 2021.

As described in the Initial Schedule 13D, pursuant to an Investment Agreement between the Issuer and the Reporting Person dated October 30, 2018 (the “Investment Agreement”), for as long as the Reporting Person owns 10% of the issued and outstanding common shares of the Issuer, the Reporting Person will be entitled to nominate one person for election or appointment to the board of directors of the Issuer (the “Board”).

The Reporting Person reserves the right to formulate other plans or make other proposals, and take other actions with respect to its interest in the Issuer. Depending on market conditions and other factors, the Reporting Person may acquire or dispose of securities of the Issuer as the Reporting Person may deem appropriate, whether in open market purchases or sales, privately negotiated transactions or otherwise. The Reporting Person continues to evaluate numerous potential transactions and in connection therewith may exchange Common Shares for other assets or may sell Common Shares to increase its cash position. The Reporting Person may also reconsider and change its plans or proposals relating to the foregoing.

Except as otherwise disclosed herein, the Reporting Person has no current plans or proposals that relate to or would result in:

(a)the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;  

(b)any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; 

(c)a sale or transfer of a material amount of the assets of the Issuer or any of its subsidiaries; 

(d)any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; 

(e)any material change in the present capitalization or dividend policy of the Issuer; 

(f)any other material change in the Issuer's business or corporate structure including, but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the United States Investment Company Act of 1940; 

(g)changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede acquisition of control of the Issuer by any person; 

(h)causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; 

(i)a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or 

(j)any action similar to any of those enumerated above. 

Item 5.Interest in Securities of the Issuer 

The filing of this statement by the Reporting Person shall not be construed as an admission that the Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act, the beneficial owners of any securities covered by the statements herein.

(a)For the purposes of this statement, the Reporting Person is reporting herein that, as of September 2, 2021 the Reporting Person was the beneficial owner of 8,206,549 shares of the Issuer's common stock, representing approximately 8.1% of the Issuer's issued and outstanding common stock. 

Page 4

(b)For the purposes of this statement, the Reporting Person is reporting herein that, as of September 2, 2021 the Reporting Person had the sole power to vote or to direct the voting of, or to dispose or to direct the disposition of 8,206,549 shares of the Issuer's common stock, representing approximately 8.1% of the Issuer's common stock.  

(c)As of the date hereof, and within the sixty day period prior thereto, no transactions involving the Issuer’s equity securities had been engaged in by the Reporting Person other than as disclosed herein.  

(d)As of the date hereof, to the best knowledge and belief of the undersigned, except as otherwise reported herein, no person other than the Reporting Person had the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. 

(e)Not applicable. 

Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer 

Pursuant to the terms of the Investment Agreement, the Reporting Person will have the right to participate in any future equity offerings of the Issuer to maintain an ownership interest in the Issuer equal to the percentage ownership prior to such an offering, provided that such ownership interest does not exceed 40% (the “Anti-Dilution Right”). Such participation right will expire at the time that the Reporting Person no longer holds 10% or more of the issued and outstanding common shares of the Issuer.

As the Reporting Person no longer holds 10% or more of the issued and outstanding common shares of the Issuer, such participation right has expired.

Except as disclosed herein, the Reporting Person does not have any contract, arrangement, understanding or relationship with respect to securities of the Issuer including, but not limited to, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, the Reporting Person has not pledged securities of the Issuer nor are the securities of the Issuer held by the Reporting Person subject to a contingency, the occurrence of which would give another person voting power or investment power over such securities.

Item 7.Material to Be Filed as Exhibits 

Page 5

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:   September 9, 2021

AUSTRALIS CAPITAL INC.

      /s/ Jon Paul

By: __________________________

Name:  Jon Paul

Title:  CFO

Page 6

EXHIBIT INDEX

Exhibit No.Description 

10.1Investment Agreement dated October 30, 2018, between the Reporting Person and the Issuer⁽¹⁾ 

10.2Conversion Agreement dated July 1, 2019, between the Reporting Person and the Issuer⁽²⁾ 

Notes:

(1)Previously filed as an exhibit to the Issuer’s Current Report on Form 8-K filed with the SEC on November 5, 2018 and incorporated by reference herein. 

(2)Previously filed as an exhibit to the Issuer’s Current Report on Form 8-K filed with the SEC on July 8, 2019 and incorporated by reference herein.